GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Other Operating Expense

WuXi XDC Cayman (HKSE:02268) Other Operating Expense : HK$-26 Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Other Operating Expense?

WuXi XDC Cayman's Other Operating Expense for the three months ended in Jun. 2023 was HK$-23 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-26 Mil.

WuXi XDC Cayman's quarterly Other Operating Expense declined from Dec. 2022 (HK$0 Mil) to Mar. 2023 (HK$-3 Mil) and declined from Mar. 2023 (HK$-3 Mil) to Jun. 2023 (HK$-23 Mil).

WuXi XDC Cayman's annual Other Operating Expense declined from Dec. 2021 (HK$-1 Mil) to Dec. 2022 (HK$-18 Mil) but then increased from Dec. 2022 (HK$-18 Mil) to Dec. 2023 (HK$19 Mil).


WuXi XDC Cayman Other Operating Expense Historical Data

The historical data trend for WuXi XDC Cayman's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Other Operating Expense Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Operating Expense
-47.00 -1.10 -17.62 18.78

WuXi XDC Cayman Quarterly Data
Dec20 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial -17.37 - -3.22 -23.08 -

WuXi XDC Cayman Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WuXi XDC Cayman Other Operating Expense Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


WuXi XDC Cayman (HKSE:02268) Business Description

Comparable Companies
Traded in Other Exchanges
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
Website
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman (HKSE:02268) Headlines

No Headlines